IMMUNOCOMPETENCE, IMMUNODEFICIENCY AND PROGNOSIS IN CANCER *

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1976-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.1976.tb41664.xPMID 800324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient.

  1976cited by this paper
• Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course

  1975cited by this paper
• Another look at immunologic surveillance.

  1975cited by this paper
• Selective immunosuppression by drugs in balanced immune responses.

  1974cited by this paper
• Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.

  1974cited by this paper
• Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatment.

  1973cited by this paper
• BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report

  1973cited by this paper
• Auto‐immunization with acute leukemia cells: Demonstration of increased lymphocyte responsiveness

  1973cited by this paper
• Expression of cell surface markers on T and B lymphocytes after long-term chemotherapy of acute leukemia.

  1973cited by this paper
• Active immunotherapy with B.C.G. for recurrent malignant melanoma.

  1973cited by this paper
• Malignant tumors arising de novo in immunosuppressed organ transplant recipients.

  1972cited by this paper
• MALIGNANT TUMORS ARISING DE NOVO IN IMMUNOSUPPRESSED ORGAN TRANSPLANT RECIPIENTS

  1972cited by this paper
• IMMUNOGLOBULIN LEVELS IN CHRONIC LYMPHOCYTIC LEUKAEMIA

  1971cited by this paper
• Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia.

  1971cited by this paper
• Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

  1971cited by this paper
• Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

  1971cited by this paper
• An Immunostimulation Theory of Tumor Development

  1971cited by this paper
• Cellular immune responses and prognosis in malignant lymphomas.

  1971cited by this paper
• Immunological Factors in Human Sarcomas and Melanomas: A Rational Basis for Immunotherapy

  1970cited by this paper
• Impaired immunologic reactivity and recurrence following cancer surgery

  1970cited by this paper
• Possible host resistance in carcinoma of the breast: a histological study.

  1968cited by this paper
• The effect of 1-beta-D-arabinofuranosylcytosine on the immune response of mice to sheep red blood cells.

  1968cited by this paper
• Effect of early thymectomy on development of mammary tumors in mice

  1965cited by this paper
• Effect of Early Thymectomy on Development of Mammary Tumours in Mice

  1964cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• The Effects of Levamisole, CORYNEBACTERIUM PARVUM, and Unblocked Lymphocytes on Mice Injected with Herpes Virus Type 2-transformed Cells

  2020cites this paper
• Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case‐control study

  2017cites this paper
• Peptide Vaccination of Patients With Metastatic Melanoma: Improved Clinical Outcome in Patients Demonstrating Effective Immunization

  2006cites this paper
• Patients Undergoing Treatment for Pancreatic Adenocarcinoma Can Mount an Effective Immune Response to Vaccinations

  2005cites this paper
• Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer

  2004cites this paper
• Verlaufsuntersuchungen unspezifischer Immunparameter bei Patienten mit Kopf-Hals-Karzinomen

  2004cites this paper
• Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen

  2002cites this paper
• Tumor-induced immune dysfunction

  1999cites this paper
• The Potential Role of Immunomodulation in the Treatment of HIV-Infection and Malignant Diseases

  1992cites this paper
• Tumor-Mediated Immunosubversion: Role of Dietary Essential Fatty Acid

  1989cites this paper
• Long‐term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma

  1987cites this paper
• Prognostic value of assays of immune competency

  1987cites this paper
• Specific application of single nutrients as a basic treatment in immunostimulating therapy.

  1987cites this paper
• Predictive value of T-cell subset derangements in lung cancer

  1986cites this paper
• Inert particles inhibit natural killer cell function in vitro.

  1986cites this paper
• Pemphigus vulgaris and malignancy.

  1985cites this paper
• Immunologic methods of diagnostic and prognostic value in tumor bearers.

  1985cites this paper
• Grundlagen der Immunologie maligner Tumoren

  1985cites this paper
• Amplification by macrophages of prostaglandin-mediated immunosuppression in mice bearing syngeneic tumors.

  1984cites this paper
• Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.

  1984cites this paper
• Elevated Levels of Anti-Malignin Antibody are Quantitatively Related to Longer Survival in Cancer Patients

  1984cites this paper
• [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].

  1984cites this paper
• Suppressor cells and survival of patients with advanced gastric cancer.

  1983cites this paper
• Immunotherapy of cancer: a critical review.

  1983cites this paper
• Malignin, Anti-Malignin Antibody and Scantag

  1983cites this paper
• Immunity in esophageal carcinoma

  1983cites this paper
• The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region

  1983cites this paper
• Levamisole in primary breast cancer. A controlled study in conjunction with L‐phenylalanine mustard

  1983cites this paper
• Suppressor cell activity in peripheral blood in cancer patients after surgery.

  1983cites this paper
• Control of Tumors by the RES

  1983cites this paper
• Modulation of antibody-dependent cellular cytotoxicity against chicken erythrocyte targets by adriamycin and daunorubicin.

  1982cites this paper
• Influence of sera from tumor bearing mice on immune reaction.

  1982cites this paper
• Biological markers and breast cancer. A multiparametric study. II: Depressed immune competence

  1982cites this paper
• Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin

  1982cites this paper
• Determination of anti-malignin antibody and malignin in 1,026 cancer patients and controls: relation of antibody to survival.

  1982cites this paper
• Potentiation of the thymosin immunoregulatory effect by hypocorticoidism in rats with DMBA-induced carcinogenesis in mammary glands.

  1982cites this paper
• Effect of indomethacin on the blastogenesis of peripheral blood lymphocyte from patients with cancer

  1982cites this paper
• Modulation of antltumoral antibody-dependent cellular eytotoxicity and natural Miler activity by Adriamyeln and daunorubicin j

  1982cites this paper
• Suppressor Cells in Tumor-Host Interactions

  1982cites this paper
• Selective plasma component removal: alternatives to plasma exchange.

  1981cites this paper
• Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.

  1981cites this paper
• Immunologic aspects of gynecologic cancer

  1981cites this paper
• Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.

  1981cites this paper
• [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].

  1981cites this paper
• Red cell immune adherence (RCIA): its application in cancer and autoimmune disease.

  1981cites this paper
• Chemotherapy of advanced ovarian epithelial carcinoma with melphalan and levamisole: a pilot study of the Gynecologic Oncology Group.

  1981cites this paper
• Chemoimmunotherapy of small cell bronchogenic carcinoma with VP‐16‐213, ifosfamide, vincristine, adriamycin, and Corynebacterium Parvum

  1981cites this paper
• [Significance off the immunological status for the disease prognosis of oncological patients].

  1981cites this paper
• Serum zinc levels in lung cancer patients

  1980cites this paper
• The immune system in gynecologic malignancies.

  1980cites this paper
• The immunostatus of untreated cervical carcinoma.

  1980cites this paper
• Tumor antigenicity and the immune system in gynecological cancer: a review.

  1980cites this paper
• Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.

  1980cites this paper
• Nutritional status and immune function in childhood cancer

  1980cites this paper
• Preoperative and postoperative immunological evaluation of patients with colorectal cancer

  1980cites this paper
• Prospects and limitations of systematic monitoring in patients with laryngeal cancer.

  1979cites this paper
• [Delayed hypersensitivity reaction in patients with metastatic testicular teratoblastoma].

  1979cites this paper
• Combined chemoimmunotherapy for advanced breast cancer. A comparison of BCG and levamisole

  1979cites this paper
• Lymphocyte functions in cancer.

  1979cites this paper
• The Effect of Age on the Character of Immune Complex Disease: A Comparison of the Incidence and Relative Size of Materials Reactive with Clq in Sera of Patients with Glomerulonephritis and Cancer

  1979cites this paper
• Cancer immunotherapy: Facts and fancy

  1979cites this paper
• The use of a leukocyte cell line culture supernatant for skin reaction testing in malignant melanoma

  1979cites this paper
• Immunobiology of head and neck cancer: basic concepts.

  1979cites this paper
• Immunologic testing as a guide to cancer management.

  1979cites this paper
• Malignant melanoma. Delayed hypersensitivity skin testing.

  1979cites this paper
• Effect of indomethacin on blastogenesis of lymphocytes from cancer patients: differentiation of patient types.

  1979cites this paper
• [The lymphocyte transformation test and its relation to the duration of disease in patients with oral carcinomas (author's transl)].

  1979cites this paper
• Recall antigen delayed-type hypersensitivity skin testing in melanoma and acute leukemia patients and their associates.

  1979cites this paper
• Dynamics of immunity in syngeneic lymphoma-bearing mice.

  1978cites this paper
• Effect of unblocking therapy and levamisole on primary gastrointestinal tumors in rats: immunologic and histologic correlation.

  1978cites this paper
• Progressive atrophy of the thymus in mice carrying Lewis lung carcinoma grafts

  1978cites this paper
• Combination chemoimmunotherapy for extensive non-oat cell lung cancer.

  1978cites this paper
• Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.

  1978cites this paper
• Komplikationen und supportive Therapie der Leukämien und malignen Non-Hodgkin-Lymphome

  1978cites this paper
• Protection against chemotherapy toxicity by IV hyperalimentation.

  1978cites this paper
• Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.

  1978cites this paper
• Multimodal immunotherapy of primary gastrointestinal tumors in rats. 1 Histologic correlation

  1978cites this paper
• Investigations on general immune reactivity in untreated cervical cancer patients.

  1978cites this paper
• Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions

  1977cites this paper
• Immunology and Immunotherapy of Human Breast Cancer

  1977cites this paper
• BCG as adjuvant immunotherapy for neoplasia.

  1977cites this paper
• [Secondary defective immunopathies].

  1977cites this paper
• A study of lung‐specific, cell‐mediated immunity in chronic pulmonary diseases

  1977cites this paper
• A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.

  1977cites this paper
• Immunotherapy of human cancer.

  1977cites this paper
• Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data.

  1977cites this paper
• DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS AND PROGNOSIS IN PATIENTS WITH CANCER

  1976cites this paper
• IN VITRO AND IN VIVO STUDIES WITH THYMOSIN IN CANCER PATIENTS *

  1976cites this paper